Real-time Estimate Cboe Europe 03:51:00 2024-04-23 am EDT 5-day change 1st Jan Change
73.4 CHF +0.27% Intraday chart for Alcon Inc. +0.71% +11.91%
Sales 2024 * 10B 9.13B Sales 2025 * 10.65B 9.72B Capitalization 39.6B 36.14B
Net income 2024 * 936M 854M Net income 2025 * 1.26B 1.15B EV / Sales 2024 * 4.25 x
Net Debt 2024 * 2.95B 2.69B Net Debt 2025 * 1.76B 1.6B EV / Sales 2025 * 3.88 x
P/E ratio 2024 *
44.1 x
P/E ratio 2025 *
34 x
Employees 25,315
Yield 2024 *
0.36%
Yield 2025 *
0.43%
Free-Float 98.58%
More Fundamentals * Assessed data
Dynamic Chart
1 day+0.99%
1 week-2.11%
Current month-2.06%
1 month-2.30%
3 months+6.99%
6 months+13.10%
Current year+11.52%
More quotes
1 week
71.18
Extreme 71.18
73.60
1 month
71.18
Extreme 71.18
76.98
Current year
62.24
Extreme 62.24
77.60
1 year
61.28
Extreme 61.28
77.60
3 years
55.22
Extreme 55.22
81.40
5 years
38.63
Extreme 38.625
81.40
10 years
38.63
Extreme 38.625
81.40
More quotes
Managers TitleAgeSince
Chief Executive Officer 58 16-06-30
Director of Finance/CFO 56 19-04-07
Chief Tech/Sci/R&D Officer - 11-05-31
Members of the board TitleAgeSince
Chairman 68 18-06-30
Director/Board Member 65 18-12-31
Director/Board Member 60 19-01-31
More insiders
Date Price Change Volume
24-04-23 73.46 +0.36% 49 196
24-04-22 73.2 +0.99% 713,956
24-04-19 72.48 +0.50% 1,101,572
24-04-18 72.12 +0.17% 743,970
24-04-17 72 -1.29% 645,904

Delayed Quote Swiss Exchange, April 22, 2024 at 11:31 am EDT

More quotes
Alcon Inc. is the global leader in the design, manufacture and marketing of ophthalmic care products. Net sales break down by category of products as follows: - ophthalmic surgical products and equipment (56.7%): consumables (51.2% of net sales), implantable products (32%) and other products (16.8%; in particular surgical equipment) for the treatment of cataracts, retinal diseases, glaucoma and refractive errors; - vision care products (43.3%): contact lenses (59.2% of sales) and eye care products (40.8%; eye drops and ophthalmic ointments, etc.) At the end of 2023, the group operated 19 production sites worldwide. Net sales are distributed geographically as follows: Switzerland (0.7%), the United States (46%), Japan (6.2%), China (5.6%) and other (41,5%).
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
28
Last Close Price
80.28 USD
Average target price
93.32 USD
Spread / Average Target
+16.25%
Consensus